Publication|Articles|August 6, 2023
- Pharmaceutical Executive: August 2023
- Volume 43
- Issue 8
Pharmaceutical Executive, August 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive August 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 2 years ago
Executive Roundtable: Innovations in Global Pharma Labelingabout 2 years ago
A Fierce Focus On Unmet Needabout 2 years ago
Pharma's ESG Equation: Materiality and Strategy are Keyabout 2 years ago
Bridging the Divide: Medical's Omnichannel Momentumabout 2 years ago
AI and Drug 'Re-Innovation'about 2 years ago
More Evidence is Pointing to Potential Swing for Biotechabout 2 years ago
2023 Proxy Season: Record Proposals, Sliding Supportabout 2 years ago
Do Findings Point to a Tarnished COVID Victory for Europe?about 2 years ago
Harnessing the Power of Communities to Combat Healthcare InequitiesNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
